Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Rinaldi

Showing results (181-190 of 231) with videos related to

Pageof 24
Sort By:
Oncotarget|November 27, 2018
Correction: Sonoporation by microbubbles as gene therapy approach against liver cancerLuca Rinaldi, Veronica Folliero, Luciana Palomba, et al.
Oncotarget|September 6, 2018
Sonoporation by microbubbles as gene therapy approach against liver cancerLuca Rinaldi, Veronica Folliero, Luciana Palomba, et al.
Diabetes Research and Clinical Practice|April 26, 2023
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR studyGiuseppe Palmiero, Arturo Cesaro, Raffaele Galiero, et al.
World Journal of Gastroenterology|February 23, 2023
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccinationRiccardo Nevola, Livio Criscuolo, Domenico Beccia, et al.
Annals of Hepatology|December 24, 2014
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease durationRosa Zampino, Maria A Pisaturo, Grazia Cirillo, et al.
World Journal of Gastroenterology|March 16, 2017
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosisLuca Rinaldi, Fabio Nascimbeni, Mauro Giordano, et al.
European Journal of Clinical Investigation|October 10, 2025
Metabolic dysfunction-associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triadAlfredo Caturano, Enes Erul, Roberto Nilo, et al.
BMC Medical Genetics|February 2, 2017
Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: identification of eleven novel pathogenic sequence variantsGabriella Esposito, Francesco Testa, Miriam Zacchia, et al.
Cardiovascular Diabetology|November 7, 2022
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trialFerdinando Carlo Sasso, Vittorio Simeon, Raffaele Galiero, et al.
Digestive Diseases and Sciences|April 3, 2019
Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life ExperienceLuca Rinaldi, Maria Guarino, Alessandro Perrella, et al.
Pageof 24

Showing results (181-190 of 231) with videos related to

Sort By:
Pageof 24
Oncotarget|November 27, 2018
Correction: Sonoporation by microbubbles as gene therapy approach against liver cancerLuca Rinaldi, Veronica Folliero, Luciana Palomba, et al.
Oncotarget|September 6, 2018
Sonoporation by microbubbles as gene therapy approach against liver cancerLuca Rinaldi, Veronica Folliero, Luciana Palomba, et al.
Diabetes Research and Clinical Practice|April 26, 2023
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR studyGiuseppe Palmiero, Arturo Cesaro, Raffaele Galiero, et al.
World Journal of Gastroenterology|February 23, 2023
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccinationRiccardo Nevola, Livio Criscuolo, Domenico Beccia, et al.
Annals of Hepatology|December 24, 2014
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease durationRosa Zampino, Maria A Pisaturo, Grazia Cirillo, et al.
World Journal of Gastroenterology|March 16, 2017
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosisLuca Rinaldi, Fabio Nascimbeni, Mauro Giordano, et al.
European Journal of Clinical Investigation|October 10, 2025
Metabolic dysfunction-associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triadAlfredo Caturano, Enes Erul, Roberto Nilo, et al.
BMC Medical Genetics|February 2, 2017
Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: identification of eleven novel pathogenic sequence variantsGabriella Esposito, Francesco Testa, Miriam Zacchia, et al.
Cardiovascular Diabetology|November 7, 2022
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trialFerdinando Carlo Sasso, Vittorio Simeon, Raffaele Galiero, et al.
Digestive Diseases and Sciences|April 3, 2019
Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life ExperienceLuca Rinaldi, Maria Guarino, Alessandro Perrella, et al.
Pageof 24